🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this pilot study is to determine the within-subjec...
Status
Completed
Location
PPD Phase 1 Unit
Start Date
2011-10
Trial ID
NCT01452542
Gaucher disease is a genetic disease that results in a deficiency of an enz...
Status
Completed
Location
New York University
Start Date
2006-06
Trial ID
NCT00358150
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy and safety...
Status
Completed
Location
University of California, San Diego Medical Center
Start Date
2010-06
Trial ID
NCT01074944
Treatments Being Tested
The primary objective of this study is to determine the effect of repeat or...
Status
Completed
Location
PPD Phase I Clinic
Start Date
2011-08
Trial ID
NCT01357811
Treatments Being Tested
The primary objective is to determine the effect of repeated oral doses of ...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01659944
Treatments Being Tested
Primary Objective: To study the effect of mild, moderate, and severe renal...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2015-09
Trial ID
NCT02536937
Treatments Being Tested
Primary Objective: To study the effect of mild and moderate hepatic impair...
Status
Completed
Location
Investigational Site Number 840002
Start Date
2015-09
Trial ID
NCT02536911
Treatments Being Tested
Primary Objective: Evaluate the efficacy and safety of eliglustat in Chine...
Status
Unknown
Location
Peking union medical college hospital
Start Date
2024-08-01
Trial ID
NCT06523517
Treatments Being Tested
Objectives: To determine pharmacokinetic (PK) variables, including absolut...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-03
Trial ID
NCT06143904
Treatments Being Tested
This Phase 3 study was designed to confirm the efficacy and safety of eligl...
Status
Completed
Location
UCSF MS Center
Start Date
2009-11
Trial ID
NCT00891202
Treatments Being Tested